Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 9/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | MMP1 | P03956 | 2/20 | 0.38 |
| ▸ | MMP2 | P08253 | 2/20 | 0.38 |
| ▸ | MMP3 | P08254 | 2/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | ACP3 | P15309 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.36 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8655114 | 0.87 | KMT2A (0.42) | KMT2AKIF11HSD11B1KCNH2HTT | |
| SCHEMBL7008086 | 0.80 | KMT2A (0.43) | KMT2AKIF11HSD11B1MMP1MMP2 | |
| SCHEMBL7049682 | 0.78 | KIF11 (0.43) | KMT2AKIF11KCNH2HTTCES2 | |
| SCHEMBL21562153 | 0.77 | CA4 (0.46) | KMT2AKIF11KCNH2 | |
| SCHEMBL17173364 | 0.77 | CA4 (0.46) | KMT2AKIF11KCNH2 | |
| SCHEMBL7924524 | 0.75 | KIF11 (0.47) | KMT2AKIF11KCNH2 | |
| SCHEMBL9306492 | 0.75 | SLC6A11 (0.45) | KMT2AKIF11HSD11B1 | |
| SCHEMBL28346610 | 0.74 | KIF11 (0.44) | KMT2AKIF11KCNH2 | |
| SCHEMBL4436554 | 0.73 | KIF11 (0.42) | KMT2AKIF11KCNH2 | |
| SCHEMBL28783455 | 0.73 | KMT2A (0.47) | KMT2AKIF11HSD11B1KCNH2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240254149-A1 | Chemical Phosphorylation Reagents, Preparation, and Their Uses | OLIX US, INC. | 2024-08-01 | — | — | US | disclosed |
| EP-4341270-A1 | CHEMICAL PHOSPHORYLATION REAGENTS, PREPARATION, AND THEIR USES | Olix US, Inc. (US) | 2024-03-27 | — | — | EP | disclosed |
| CN-117580848-A | Chemical phosphorylating reagent, preparation and use thereof | 奥利克斯美国公司 | 2024-02-20 | — | — | CN | disclosed |
| WO-2022246196-A1 | CHEMICAL PHOSPHORYLATION REAGENTS, PREPARATION, AND THEIR USES | OLIX US, INC. (US) | 2022-11-24 | — | — | WO | disclosed |
| EP-0816368-B1 | Chemical phoshorylation of oligonucleotides and reactants used therefor | GLEN RES CORP (US) | 2003-01-08 | — | — | EP | disclosed |
| US-5959090-A | FORMING PHOSPHORAMIDITE COMPOUNDS FROM PHOSPHORYLATION | GLEN RESEARCH CORPORATION (US) | 1999-09-28 | — | — | US | disclosed |
| EP-0816368-A1 | Chemical phoshorylation of oligonucleotides and reactants used therefor | Glen Research Corporation (US) | 1998-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240254149-A1 | Chemical Phosphorylation Reagents, Preparation, and Their Uses | PTMS, PPP4C, CHAMP1 | KMT2A 2135/4885KIF11 1762/4885HSD11B1 3917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.